Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P3SY
|
||||
Former ID |
DAP001363
|
||||
Drug Name |
Danaparoid
|
||||
Synonyms |
Orgaran (TN)
|
||||
Therapeutic Class |
Anticoagulants
|
||||
Company |
Schering-Plough
|
||||
CAS Number |
CAS 83513-48-8
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor Xa | Target Info | Inhibitor | [535592] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Beta2 integrin cell surface interactions | ||||
PathWhiz Pathway | Coagulation | ||||
Reactome | Extrinsic Pathway of Fibrin Clot Formation | ||||
Intrinsic Pathway of Fibrin Clot Formation | |||||
Common Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
References | |||||
Ref 535201 | A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thromb Haemost. 2001 Jun;85(6):950-7. | ||||
Ref 541886 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6804). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.